December 15 - December 17, 2022 43rd Meeting of the European Organization of Research and Treatment of Cancer (EORTC), Pharmacology and Molecular Mechanisms (PAMM) group
Sep 29, 2026 Propanc Biopharma Provides Corporate Update & Year-End June 30, 2025-26, Financial Results
Sep 22, 2026 Propanc Biopharma Highlights Differentiated PRP Pancreatic Cancer Data Versus Emerging Pan-RAS Program ERAS-0015
